Dimitris Papantoniou
PhD student at Department of Medical Sciences; Endocrine Oncology
- Mobile phone:
- +46 70 043 52 18
- E-mail:
- dimitris.papantoniou@medsci.uu.se
- Visiting address:
- Rudbecklaboratoriet, R3, 2 tr
751 85 UPPSALA - Postal address:
- Rudbecklaboratoriet, R3, 2 tr
751 85 UPPSALA
Publications
Recent publications
Small Intestinal neuroendocrine tumours Grade 2: Studies of tumour biology and treatment
2025
Part of Journal of neuroendocrinology, 2024
- DOI for Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
- Download full text (pdf) of Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
Part of Endocrine-Related Cancer, 2023
- DOI for Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
- Download full text (pdf) of Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
Part of BMC Cancer, 2023
- DOI for Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
- Download full text (pdf) of Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
Systemic treatment in patients with malignant pleural mesothelioma - real life experience
Part of BMC Cancer, 2022
- DOI for Systemic treatment in patients with malignant pleural mesothelioma - real life experience
- Download full text (pdf) of Systemic treatment in patients with malignant pleural mesothelioma - real life experience
All publications
Articles in journal
Part of Journal of neuroendocrinology, 2024
- DOI for Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
- Download full text (pdf) of Hypoalbuminemia, but not derived neutrophil to lymphocyte ratio (dNLR), predicts overall survival in neuroendocrine tumours undergoing peptide receptor radionuclide therapy: A retrospective, cohort study of 557 patients
Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
Part of Endocrine-Related Cancer, 2023
- DOI for Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
- Download full text (pdf) of Treatment efficacy in a metastatic small intestinal neuroendocrine tumour grade 2 cohort
Part of BMC Cancer, 2023
- DOI for Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
- Download full text (pdf) of Activity and safety of KEES-an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer
Systemic treatment in patients with malignant pleural mesothelioma - real life experience
Part of BMC Cancer, 2022
- DOI for Systemic treatment in patients with malignant pleural mesothelioma - real life experience
- Download full text (pdf) of Systemic treatment in patients with malignant pleural mesothelioma - real life experience
Part of Endocrine, p. 893-904, 2021
- DOI for Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2
- Download full text (pdf) of Assessment of hormonal levels as prognostic markers and of their optimal cut-offs in small intestinal neuroendocrine tumours grade 2